Phage display-derived human antibodies in clinical development and therapy
about
High affinity nanobodies against human epidermal growth factor receptor selected on cells by E. coli display.Mining gut microbiome oligopeptides by functional metaproteome display.A Recombinant Human Anti-Platelet scFv Antibody Produced in Pichia pastoris for Atheroma Targeting.Therapeutic targeting in nanomedicine: the future lies in recombinant antibodies.Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery.Development of an Affimer-antibody combined immunological diagnosis kit for glypican-3.Cell-free synthesis of functional antibodies using a coupled in vitro transcription-translation system based on CHO cell lysatesDesign and Characterization of a Human Monoclonal Antibody that Modulates Mutant Connexin 26 Hemichannels Implicated in Deafness and Skin DisordersDesigning Human Antibodies by Phage DisplayEscherichia coli surface display for the selection of nanobodies.Prediction of delayed retention of antibodies in hydrophobic interaction chromatography from sequence using machine learning.Construction of Bovine Immunoglobulin Libraries in the Single-Chain Fragment Variable (scFv) Format.Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics.Antibody-Based Protective Immunity against Helminth Infections: Antibody Phage Display Derived Antibodies against BmR1 Antigen.Construction of Macaque Immune-Libraries.Construction of Synthetic Antibody Phage-Display Libraries.Epitope Mapping by Phage Display.Engineering of Fc Fragments with Optimized Physicochemical Properties Implying Improvement of Clinical Potentials for Fc-Based Therapeutics.Preclinical Optimization of Antibody-based Radiopharmaceuticals for Cancer Imaging and Radionuclide Therapy - Model, Vector, and Radionuclide Selection.The Immunogenetics of Psoriasis and Implications for Drug Repositioning.Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy.Chickens with humanized immunoglobulin genes generate antibodies with high affinity and broad epitope coverage to conserved targets.Parallelized Antibody Selection in Microtiter Plates.Construction of a Synthetic Antibody Gene Library for the Selection of Intrabodies and Antibodies.Construction of Human Immune and Naive scFv Libraries.Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancer.Isolation and Characterization of Novel Phage Displayed scFv Fragment for Human Tumor Necrosis Factor Alpha and Molecular Docking Analysis of Their Interactions.Antibody-Mediated Therapy against HIV/AIDS: Where Are We Standing Now?Construction of Synthetic Phage Displayed Fab Library with Tailored DiversitySurface-Engineered Lentiviral Vectors for Selective Gene Transfer into Subtypes of LymphocytesSelection of Antibodies with Tailored Properties by Application of High-Throughput Multiparameter Fluorescence-Activated Cell Sorting of Yeast-Displayed Immune Libraries
P2860
Q36089600-86CF848F-B15B-4E16-A838-80C7AF196DFAQ36153085-CC392613-7D14-4AAA-956E-FF58136F34CEQ36261019-8097A692-9185-4908-8888-2B61526006E5Q38658279-0755315C-7C86-48BC-B883-88A0ABA593E0Q38922319-1EF1417B-F580-4B2F-A185-E728B1ED46ACQ41550210-59AC5AC0-40BD-4576-B025-82C4FAF9083CQ41697029-5E9632C5-D9EA-4EA5-A064-4E722DEED2EDQ42172814-9D7B3357-A47A-4F74-AAB9-5771EAD26E3DQ42660134-3857C219-B325-46E1-849D-CF04BA52DDB3Q42770832-71C16F89-87AF-4C2F-BA23-30F090BEF3BFQ45945330-9F151702-D19E-4CA8-B14E-A468BDA6630CQ46265817-1C19F7C0-EE71-4CD9-A446-85A827D10686Q47099672-E003026B-E815-427B-9790-F47A682497CAQ47102082-E0514A4B-9BD4-4F15-A273-6217233601E3Q47369432-4513947D-2FEE-4152-B674-011FFCEB0D2AQ47369438-206DB771-0D04-4EE8-A5A9-F67FCA15CFFDQ47425492-36FEF332-5206-4E26-BC5A-DD1200BEF387Q47548498-CFC5B69E-FA3A-48E4-B124-C1F24B89291BQ48089417-7D2D0760-A03C-4D36-8C07-0A676A2A7BE7Q48324692-B097A9BB-514F-40E8-8113-0729B01AA317Q49592680-50A18F4A-0CEA-4BB4-9349-98D350DA54CBQ50073562-6A34951B-FDA5-4AA2-9821-7153AB6FABBCQ50108502-0C24BAE0-3295-486B-A090-E928D54D9311Q50108511-8BC518E6-91EB-43F8-9C97-22AEE1D2A091Q50108558-10B9107F-CC32-4218-89E3-0C36A493B2CEQ52568663-37F82207-7A55-4BE7-9CA9-FE40A1EFD5F7Q55005044-30E810CF-A6D1-444A-8C82-E0405191704DQ55436995-CD84036B-4A9C-4462-AF02-AF6459342D83Q56889426-E77A4503-A3CC-4E9C-AAC6-FBF55D664640Q58726929-D8062DBC-3C56-40FA-8A14-98883F295D38Q58800884-A7679EB7-7E9A-4B17-9FF5-4B4207DE7CCF
P2860
Phage display-derived human antibodies in clinical development and therapy
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Phage display-derived human antibodies in clinical development and therapy
@en
type
label
Phage display-derived human antibodies in clinical development and therapy
@en
prefLabel
Phage display-derived human antibodies in clinical development and therapy
@en
P2860
P921
P1476
Phage display-derived human antibodies in clinical development and therapy
@en
P2093
André Frenzel
Thomas Schirrmann
P2860
P304
P356
10.1080/19420862.2016.1212149
P50
P577
2016-07-14T00:00:00Z
2016-10-01T00:00:00Z